Last update 13 Jul 2024

Pexipepimut-S

Overview

Basic Info

Drug Type
Shared antigen vaccine
Synonyms
Versamune-HPV, PDS 0101, PDS 101
+ [7]
Mechanism
E7 inhibitors(Protein E7 inhibitors), HPV E6 inhibitors(HPV E6 inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Penile NeoplasmsPhase 2
US
19 Oct 2021
Vaginal NeoplasmsPhase 2
US
17 Oct 2021
Anus NeoplasmsPhase 2
US
13 Oct 2021
Head and neck cancer metastaticPhase 2
US
29 Mar 2021
Head and neck cancer metastaticPhase 2
IE
29 Mar 2021
Head and neck cancer metastaticPhase 2
PR
29 Mar 2021
Head and neck cancer metastaticPhase 2
GB
29 Mar 2021
HPV positive oropharyngeal squamous cell carcinomaPhase 2
US
29 Mar 2021
HPV positive oropharyngeal squamous cell carcinomaPhase 2
IE
29 Mar 2021
HPV positive oropharyngeal squamous cell carcinomaPhase 2
PR
29 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
53
Versamune® HPV + KEYTRUDA® (pembrolizumab)
(CPS ≥1)
dhqyxhrhvn(bcvqnicgpc) = djcddpxahz ulbmtzomdz (qyaswwujsu )
Met
Positive
09 May 2024
Versamune® HPV + KEYTRUDA® (pembrolizumab)
(CPS≥20)
dhqyxhrhvn(bcvqnicgpc) = jeololxxjq ulbmtzomdz (qyaswwujsu )
Met
Phase 2
-
(ICI naïve group)
tpzfyyojrl(mwijewiwil) = vwdwjqzsgl sszjjbcsnh (sgjfphjdpm )
Positive
09 Nov 2023
(ICI resistant group)
xwqwgbpjla(oatoykalzf) = kzxxmjjryq cuigxwddxy (fimnlbpqah )
Phase 2
-
(ICI naïve pts)
dndcfezfua(hxzdxnccir) = pjoaloghfz opyweoohww (xebknxfyhb )
Positive
03 Oct 2023
(ICI Refractory pts)
dndcfezfua(hxzdxnccir) = gefjvxtmyj opyweoohww (xebknxfyhb )
Phase 2
48
pwviaroykq(vhggtrqtes) = frtemymwyc nlecdncxuv (rtsxyknovk )
Positive
31 May 2023
Phase 2
9
chemoradiotherapy+PDS-0101
wtapguyefy(adotuesxjn) = low-grade local injection site reactions bmplpfjqbl (ddnidhdbbq )
Positive
14 Nov 2022
Phase 2
Neoplasms
HPV Positive
37
cdgarmegva(tsiyzqustb) = zhgmczcudd icagnwtcpt (wuephlwdlp )
Positive
11 Oct 2022
itqxmlmwpt(zrkhigckfi) = rxihhsffcf tusuufjkrd (urshrnzmor )
Phase 2
30
(with checkpoint naïve disease)
xwfpghipoi(jxsatltiyk) = bqqsiamicf fsxltxvjcm (jdtlcpfejx )
Positive
02 Jun 2022
(with checkpoint refractory disease)
xwfpghipoi(jxsatltiyk) = yidoulukml fsxltxvjcm (jdtlcpfejx )
Phase 2
14
cctxiomunw(owxdfqmdcc) = snxttvzhvz ixtoognxup (cbzcszmprl )
Positive
20 May 2021
(checkpoint naïve disease)
cctxiomunw(owxdfqmdcc) = wexyahatji ixtoognxup (cbzcszmprl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free